Abstract:The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Biocompatible and Ph-Sensitive Peg Hydrogels with Degradable Phosphoester and Phosphoamide Linkers End-Capped with Amine for Controlled Drug Delivery

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-Caprolactone) and Poly(ethylene Glycol)co-Polymer

Novel Amphiphilic, Biodegradable, Biocompatible, Cross-Linkable Copolymers: Synthesis, Characterization and Drug Delivery Applications

Crosslinked Poly(ethylene Glycol) Hydrogels with Degradable Phosphamide Linkers Used As a Drug Carrier in Cancer Therapy

Cross-Linked PEG via Degradable Phosphate Ester Bond: Synthesis, Water-Swelling, and Application as Drug Carrier

Hydrolytically Degradable Hyperbranched Peg-Polyester Adhesive With Low Swelling And Robust Mechanical Properties

Hydrolytically Degradable Hyperbranched PEG‐Polyester Adhesive with Low Swelling and Robust Mechanical Properties

A hyperbranched amphiphilic acetal polymer for pH-sensitive drug delivery

Photo-cross-linked hydrogels from thermoresponsive PEGMEMA-PPGMA-EGDMA copolymers containing multiple methacrylate groups: mechanical property, swelling, protein release, and cytotoxicity.

Biodegradable Strain-Promoted Click Hydrogels for Encapsulation of Drug-Loaded Nanoparticles and Sustained Release of Therapeutics

Synthesis and Physicochemical Characterization of Biodegradable and Ph‐responsive Hydrogels Based on Polyphosphoester for Protein Delivery

Photo-cross-linked biodegradable hydrogels based on n-arm-poly(ethylene glycol), poly(ε-caprolactone) and/or methacrylic acid for controlled drug release.

Preparation and Properties of Hydrogels Based on Peg and Isosorbide Building Blocks with Phosphate Linkages

A Ph-Sensitive and Biodegradable Supramolecular Hydrogel Constructed from a PEGylated Polyphosphoester-Doxorubicin Prodrug and Α-Cyclodextrin

Fully biodegradable self-healing hydrogel prepared based on poly(aspartic acid) and pectin for drug delivery and anti-tumor therapy

Injectable supramolecular hydrogels fabricated from PEGylated doxorubicin prodrug and α-cyclodextrin for pH-triggered drug delivery

Preparation and Properties of Degradable Hydrogels Based on Diallyl Terminated Cyclic Acetal and PEG Monomer

Ph-Sensitive Interpenetrating Network Hydrogels Based on Pachyman and Its Carboxymethylated Derivatives for Oral Drug Delivery

Injectable Supramolecular Hydrogels Fabricated From Pegylated Doxorubicin Prodrug And Alpha-Cyclodextrin For Ph-Triggered Drug Delivery

Ph-Sensitive Carboxymethyl Chitosan Hydrogels Via Acid-Labile Ortho Ester Linkage for Potential Biomedical Applications.

Injectable Block Copolymer Hydrogels for Sustained Release of a PEGylated Drug